Nitrogen

Description

Nitrogen, compressed NF, is a colorless, odorless gas. Its Chemical Abstracts Service (CAS) number is 7727-37-9.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrogen administration, which may contraindicate its use in certain patients or conditions. There are no specific teratogenic or nonteratogenic effects reported for this drug.

Dosage and Administration

Administration of this medication is restricted to licensed practitioners who possess experience in the use and administration of Nitrogen. These practitioners must be well-versed in the indications, effects, dosages, methods, and frequency and duration of administration.

The medication is to be administered via the respiratory route, specifically through inhalation. Practitioners should ensure that the administration technique is appropriate for inhalation to achieve optimal therapeutic effects. The specific dosage and frequency of administration should be determined based on individual patient needs and clinical judgment, adhering to established guidelines for Nitrogen use.

Contraindications

There are no specific contraindications identified for this product. However, it is essential to adhere to the following precautions to ensure safe handling and use:

• Handling should only occur after all safety precautions have been thoroughly read and understood.

• The product must be used and stored exclusively outdoors or in a well-ventilated area to mitigate potential risks associated with inadequate ventilation.

• Connections should not be altered or forced, as this may compromise safety and functionality.

Warnings and Precautions

Administration of Nitrogen may pose significant risks and is contraindicated in certain situations. It is imperative that this substance is used solely by or under the supervision of a licensed practitioner who possesses expertise in the use and administration of Nitrogen. This includes familiarity with its indications, effects, dosages, methods, frequency and duration of administration, as well as an understanding of the associated hazards, contraindications, side effects, and necessary precautions.

The product contains gas under pressure, which may lead to explosive hazards if subjected to heat. Additionally, it has the potential to displace oxygen, resulting in rapid suffocation. Therefore, it is crucial to read and comprehend all safety precautions prior to handling. Nitrogen should only be used and stored outdoors or in well-ventilated areas. A backflow preventive device must be utilized in the piping, and only equipment rated for cylinder pressure should be employed. The valve should be closed after each use and when the cylinder is empty. Protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F). It is essential to consult and adhere to the Safety Data Sheet (SDS) before use.

Furthermore, the product contains refrigerated gas, which can cause cryogenic burns or injuries and may also displace oxygen, leading to rapid suffocation. Similar to the aforementioned precautions, handling should only occur after all safety measures have been thoroughly understood. The gas must be used and stored in well-ventilated areas, and appropriate personal protective equipment, including cold insulating gloves, face shields, and eye protection, should be worn. Connections should not be changed or forced, and the container must always be kept in an upright position. Again, consulting the Safety Data Sheet (SDS) prior to use is strongly advised.

In the event of an emergency, specific first aid measures should be taken. If Nitrogen is inhaled, the individual should be removed to fresh air and kept comfortable for breathing. Medical advice or attention should be sought immediately. If the gas comes into contact with skin, it is important to thaw any frosted areas with lukewarm water without rubbing the affected area. Immediate medical advice or attention is also necessary in this case.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product. Serious risks include the possibility of cryogenic burns or injury due to the presence of refrigerated gas. Inhalation of the gas may lead to rapid suffocation as it can displace oxygen in the environment.

In the event of inhalation, it is crucial to remove the affected individual to fresh air and ensure they are comfortable for breathing. If the gas comes into contact with the skin, it is recommended to thaw any frosted areas with lukewarm water without rubbing the affected skin. Immediate medical advice or attention should be sought in such cases to prevent further complications.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for Nitrogen, including recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this drug in pediatric patients due to the absence of relevant data.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Administration of Nitrogen during pregnancy may pose potential risks to both the pregnant patient and the developing fetus. The use of Nitrogen is contraindicated or may be hazardous, and it is recommended that it be administered only by or under the supervision of a licensed practitioner experienced in its use.

Healthcare professionals should exercise caution when considering the use of Nitrogen in pregnant patients, as the implications for fetal outcomes are not fully understood. Given the potential risks associated with its administration, it is essential to weigh the benefits against the possible hazards before proceeding with treatment in this population.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. It is recommended to weigh the potential benefits against any unknown risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available prescribing information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while no specific overdosage information is provided, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No specific postmarketing experience details are available. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who is experienced in its use and administration. This practitioner should be familiar with the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the warning that Nitrogen contains gas under pressure, which may explode if heated. Additionally, it may displace oxygen and cause rapid suffocation, emphasizing the importance of understanding safety precautions before handling. Patients should be instructed to use and store Nitrogen only outdoors or in a well-ventilated area. It is crucial to use a backflow preventive device in the piping and to ensure that all equipment is rated for cylinder pressure.

Healthcare providers should remind patients to close the valve after each use and when the cylinder is empty. They should also protect the cylinder from sunlight when the ambient temperature exceeds 52°C (125°F) and read and follow the Safety Data Sheet (SDS) prior to use.

In the event of inhalation, patients should be instructed to remove themselves to fresh air and keep comfortable for breathing, while seeking medical advice or attention. Providers should also inform patients of the risk of cryogenic burns or injury due to the refrigerated gas contained in Nitrogen. Patients should wear cold insulating gloves, a face shield, and eye protection when handling the gas.

It is important to advise patients not to change or force fit connections and to always keep the container in an upright position. In case of skin contact, patients should thaw frosted areas with lukewarm water without rubbing the affected area and seek immediate medical advice or attention.

Storage and Handling

The product is supplied in a manner that necessitates careful handling and storage to ensure safety and efficacy. It is essential to use and store the product exclusively outdoors or in a well-ventilated area. When ambient temperatures exceed 52°C (125°F), the product must be protected from direct sunlight to prevent degradation.

After each use and when the container is empty, the valve should be securely closed. It is critical to maintain the container in an upright position at all times to prevent leaks or spills. Personnel handling the product must wear appropriate protective equipment, including cold insulating gloves, a face shield, and eye protection.

To ensure safe operation, a backflow preventive device should be utilized in the piping system. Prior to handling the product, all safety precautions must be thoroughly read and understood. It is also important to avoid changing or forcing any connections to maintain the integrity of the system.

Additional Clinical Information

Administration of Nitrogen is indicated via respiratory inhalation. Clinicians should be aware that the use of Nitrogen may pose hazards and is contraindicated in certain situations. It is essential that administration is conducted only by or under the supervision of a licensed practitioner experienced in its use, who understands the indications, effects, dosages, methods, and potential side effects.

Patients should be counseled on the risks associated with Nitrogen, including the presence of gas under pressure, which may explode if heated, and the potential for rapid suffocation due to oxygen displacement. Safety precautions must be thoroughly understood before handling, including the necessity of using and storing the gas outdoors or in well-ventilated areas, employing back flow preventive devices, and ensuring proper equipment is used. Additionally, the gas is refrigerated and may cause cryogenic burns; therefore, protective gear such as cold insulating gloves and eye protection is recommended. In case of inhalation or skin contact, immediate first aid measures should be taken, including moving the affected individual to fresh air and seeking medical attention.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by S. J. Smith Co. , Inc.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)